首页 > 最新文献

Pneumologie最新文献

英文 中文
[Intended and unintended effects of e-cigarettes in clinical studies: a plea for (more) transparency]. [电子烟在临床研究中的预期效果和意外效果:要求(更多)透明度]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-01-24 DOI: 10.1055/a-2243-9399
Reiner Hanewinkel, Sabina Ulbricht

E-cigarettes are used in clinical trials to facilitate smoking cessation. Due to the health risks associated with the use of e-cigarettes, the results of clinical trials should be fully reported, including continued exclusive use and dual use of tobacco and e-cigarettes. Nicotine cessation outcomes should be reported as the primary endpoint as well as the analysis of tobacco cessation alone. As there is currently no robust evidence that reducing cigarette consumption provides substantial health benefits, cigarette consumption reduction should not be used as a health outcome in clinical trials. Continued nicotine dependence should be included as an "adverse event" in the reporting of trial results.

临床试验中使用电子烟来促进戒烟。由于使用电子烟存在健康风险,临床试验结果应全面报告,包括继续完全使用以及烟草和电子烟的双重使用。尼古丁戒断结果应作为主要终点以及单独戒烟分析进行报告。由于目前还没有有力的证据表明减少香烟消费会带来实质性的健康益处,因此在临床试验中不应将减少香烟消费作为一项健康结果。在报告试验结果时,持续尼古丁依赖应被列为 "不良事件"。
{"title":"[Intended and unintended effects of e-cigarettes in clinical studies: a plea for (more) transparency].","authors":"Reiner Hanewinkel, Sabina Ulbricht","doi":"10.1055/a-2243-9399","DOIUrl":"10.1055/a-2243-9399","url":null,"abstract":"<p><p>E-cigarettes are used in clinical trials to facilitate smoking cessation. Due to the health risks associated with the use of e-cigarettes, the results of clinical trials should be fully reported, including continued exclusive use and dual use of tobacco and e-cigarettes. Nicotine cessation outcomes should be reported as the primary endpoint as well as the analysis of tobacco cessation alone. As there is currently no robust evidence that reducing cigarette consumption provides substantial health benefits, cigarette consumption reduction should not be used as a health outcome in clinical trials. Continued nicotine dependence should be included as an \"adverse event\" in the reporting of trial results.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial. YoungDGP 试点项目 "气动快速约会"--具有未来潜力的创新培训形式。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-08-19 DOI: 10.1055/a-2281-4767
Erik Büscher, Wolfram Windisch, Jutta Kappes, Dirk Skowasch, Michael Kreuter, Julia Wälscher
{"title":"YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial.","authors":"Erik Büscher, Wolfram Windisch, Jutta Kappes, Dirk Skowasch, Michael Kreuter, Julia Wälscher","doi":"10.1055/a-2281-4767","DOIUrl":"10.1055/a-2281-4767","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare Example of abnormal vocal resonance: a case from Balzac's novel. 异常声带共鸣的罕见实例:巴尔扎克小说中的一个案例。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-02-21 DOI: 10.1055/a-2248-9672
Volodymyr Berezutskyi, Maryna Berezutska

Ungewöhnliche klinische Fälle wecken bei praktizierenden Ärzten immer wieder Interesse und ermöglichen es ihnen, ihre Wissensbasis zu erweitern und ihre Fähigkeiten zum klinischen Denken zu verbessern. Der Zweck dieser Studie besteht darin, einen klinischen Fall von Stimmresonanz beim Singen bei einem schwindsüchtigen Teenager aus dem Roman "Der Landarzt" von Honoré de Balzac unter Verwendung induktiver und deduktiver Methoden des klinischen Denkens zu analysieren. Stimmresonanzen beim Singen in Schwindsucht können als pathognomonisches Zeichen für eine kavernöse Tuberkulose gewertet werden, da nur mit dem Bronchus verbundene Hohlräume als Helmholtz-Resonator wirken. Trotz der Einzigartigkeit ist das Gehäuse durchaus realistisch, da es nicht im Widerspruch zu den Gesetzen der Akustik steht. Praktizierende Ärzte verfügen über die Kenntnisse der medizinischen Physik, Morphologie und Physiologie, die zum Verständnis der Pathogenese der klinischen Manifestation einer Lungenhöhle erforderlich sind. Dieser Fall zeigt deutlich die Vor- und Nachteile klinischer Denkmethoden, die in der Praxis eingesetzt werden. Dank der Kombination aus Originalität und Realismus kann der Fall von Stimmresonanz aus Balzacs Roman "Der Landarzt" seinen rechtmäßigen Platz in der persönlichen Sammlung klinischer Fälle eines jeden Lungenarztes einnehmen.

不寻常的临床病例总是能吸引执业医师的兴趣,并让他们拓展知识基础,提高临床推理能力。本研究旨在运用归纳和演绎的临床推理方法,分析奥诺雷-德-巴尔扎克的小说《乡村医生》中一个患有肺痨的少年在唱歌时出现声带共鸣的临床病例。肺痨患者唱歌时的声带共鸣可被解释为空洞型肺结核的病征,因为只有与支气管相连的空洞才会产生亥姆霍兹共鸣。尽管该病例很独特,但却很现实,因为它并不违背声学规律。执业医生具备理解肺空洞临床表现的发病机理所需的医学物理、形态学和生理学知识。本病例清楚地展示了临床推理方法在实际应用中的优缺点。巴尔扎克小说《乡村医生》中的嗓音共鸣病例集独创性和现实性于一身,因此可以在每位肺科医生的个人临床病例收藏中占据应有的位置。
{"title":"Rare Example of abnormal vocal resonance: a case from Balzac's novel.","authors":"Volodymyr Berezutskyi, Maryna Berezutska","doi":"10.1055/a-2248-9672","DOIUrl":"10.1055/a-2248-9672","url":null,"abstract":"<p><p>Ungewöhnliche klinische Fälle wecken bei praktizierenden Ärzten immer wieder Interesse und ermöglichen es ihnen, ihre Wissensbasis zu erweitern und ihre Fähigkeiten zum klinischen Denken zu verbessern. Der Zweck dieser Studie besteht darin, einen klinischen Fall von Stimmresonanz beim Singen bei einem schwindsüchtigen Teenager aus dem Roman \"Der Landarzt\" von Honoré de Balzac unter Verwendung induktiver und deduktiver Methoden des klinischen Denkens zu analysieren. Stimmresonanzen beim Singen in Schwindsucht können als pathognomonisches Zeichen für eine kavernöse Tuberkulose gewertet werden, da nur mit dem Bronchus verbundene Hohlräume als Helmholtz-Resonator wirken. Trotz der Einzigartigkeit ist das Gehäuse durchaus realistisch, da es nicht im Widerspruch zu den Gesetzen der Akustik steht. Praktizierende Ärzte verfügen über die Kenntnisse der medizinischen Physik, Morphologie und Physiologie, die zum Verständnis der Pathogenese der klinischen Manifestation einer Lungenhöhle erforderlich sind. Dieser Fall zeigt deutlich die Vor- und Nachteile klinischer Denkmethoden, die in der Praxis eingesetzt werden. Dank der Kombination aus Originalität und Realismus kann der Fall von Stimmresonanz aus Balzacs Roman \"Der Landarzt\" seinen rechtmäßigen Platz in der persönlichen Sammlung klinischer Fälle eines jeden Lungenarztes einnehmen.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139932490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1 Million beatmete Patienten in Deutschland: Eine komplette Übersicht über die Jahre 2019–2022. 德国 100 万名呼吸机患者:2019-2022 年完整概览。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-06-12 DOI: 10.1055/a-2341-6337
Norbert Suttorp
{"title":"1 Million beatmete Patienten in Deutschland: Eine komplette Übersicht über die Jahre 2019–2022.","authors":"Norbert Suttorp","doi":"10.1055/a-2341-6337","DOIUrl":"10.1055/a-2341-6337","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141311492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial. 勘误:YoungDGP 试点项目 "气动快速约会"--具有未来潜力的创新培训形式。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-08-22 DOI: 10.1055/a-2395-6368
E Büscher, W Windisch, J Kappes, D Skowasch, M Kreuter, J Wälscher
{"title":"Erratum: YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial.","authors":"E Büscher, W Windisch, J Kappes, D Skowasch, M Kreuter, J Wälscher","doi":"10.1055/a-2395-6368","DOIUrl":"https://doi.org/10.1055/a-2395-6368","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Brain metastases]. [脑转移]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-08-01 Epub Date: 2024-01-24 DOI: 10.1055/a-2238-1840
Christian Schulz, Martin Proescholdt, Nils Ole Schmidt, Felix Steger, Daniel Heudobler

Cerebral metastases in patients with metastatic lung cancer are found in more than 30% of patients at baseline and manifest themselves in two out of three patients during disease evolution. For a long time, the cerebral manifestation of the disease was classified as prognostically unfavorable and hence such patients were regularly excluded from therapy studies. In the context of targeted molecular therapy strategies and established immuno-oncological systemic therapies, the blood-brain barrier no longer represents an insurmountable barrier. However, the treatment of brain metastases requires decision making in a multidisciplinary team within dedicated lung cancer and/or oncology centers. The differentiated treatment decision is based on the number, size and location of the brain metastases, neurology and general condition, comorbidities, potential life expectancy and the patient's wishes, but also tumor biology including molecular targets, extra-cranial tumor burden and availability of a CNS-effective therapy. Systemic therapies as well as neurosurgical and radiotherapeutic concepts are now often combined for optimized and prognosis-improving therapeutic strategies.

在转移性肺癌患者中,有 30% 以上的患者在基线时就发现了脑转移灶,在疾病演变过程中,每三名患者中就有两名出现脑转移灶。长期以来,这种疾病的脑部表现被归类为预后不良,因此这类患者经常被排除在治疗研究之外。在分子靶向治疗策略和成熟的免疫肿瘤系统疗法的背景下,血脑屏障不再是不可逾越的障碍。然而,脑转移瘤的治疗需要在专门的肺癌和/或肿瘤中心内由多学科团队做出决策。差异化治疗决策基于脑转移瘤的数量、大小和位置、神经病学和全身状况、合并症、潜在预期寿命和患者意愿,以及肿瘤生物学,包括分子靶点、颅外肿瘤负荷和中枢神经系统有效疗法的可用性。现在,全身疗法以及神经外科和放射治疗理念经常被结合起来,以优化和改善预后的治疗策略。
{"title":"[Brain metastases].","authors":"Christian Schulz, Martin Proescholdt, Nils Ole Schmidt, Felix Steger, Daniel Heudobler","doi":"10.1055/a-2238-1840","DOIUrl":"10.1055/a-2238-1840","url":null,"abstract":"<p><p>Cerebral metastases in patients with metastatic lung cancer are found in more than 30% of patients at baseline and manifest themselves in two out of three patients during disease evolution. For a long time, the cerebral manifestation of the disease was classified as prognostically unfavorable and hence such patients were regularly excluded from therapy studies. In the context of targeted molecular therapy strategies and established immuno-oncological systemic therapies, the blood-brain barrier no longer represents an insurmountable barrier. However, the treatment of brain metastases requires decision making in a multidisciplinary team within dedicated lung cancer and/or oncology centers. The differentiated treatment decision is based on the number, size and location of the brain metastases, neurology and general condition, comorbidities, potential life expectancy and the patient's wishes, but also tumor biology including molecular targets, extra-cranial tumor burden and availability of a CNS-effective therapy. Systemic therapies as well as neurosurgical and radiotherapeutic concepts are now often combined for optimized and prognosis-improving therapeutic strategies.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139545675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negative impact of face masks in patients with interstitial lung disease: A prospective study. 口罩对间质性肺病患者的负面影响:前瞻性研究。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-07-30 DOI: 10.1055/a-2361-4723
Arno Mohr, Stefanie Zahn, Florian Geismann, Stefan Blaas, Michael Pfeifer, Maximilian Malfertheiner, Bernd Salzberger, Frank Hanses, Stilla Bauernfeind, Myriam Koch, Florian Hitzenbichler

Introduction: Face masks increase airway resistance, data on the actual extent of this effect are scarce. The aim of this study was to assess the effect of different mask types on clinical parameters during moderate exercise in healthy non-smokers, active smokers and patients with interstitial lung disease (ILD) without the need of oxygen therapy.

Methods: In a prospective observational pilot study participants performed a six-minute walk test without mask, with a surgical mask, a well-fitted FFP2 mask and with a valved FFP3 mask. Respiratory rate, blood pressure, heart rate, blood gas analysis parameters, dyspnoea and six-minute walk distance were measured. Data were analysed in an ANOVA model.

Results: 21 healthy participants, 17 active smokers without known pulmonary disease and 15 patients with interstitial lung disease were included. Participants with ILD had a significant lower walking distance, a higher respiratory rate and a lower pO2 when using FFP2 masks, but not with valved FFP3 masks or surgical masks compared to not wearing a mask.

Conclusion: For patients with ILD without the need of oxygen therapy wearing an FFP2 mask had a negative impact on pO2, respiratory rate and walking distance in the six-minute walk test. This effect was not seen with valved FFP3 masks or surgical masks.

简介:口罩会增加气道阻力,但有关这种影响的实际程度的数据却很少。本研究旨在评估不同类型的口罩对健康非吸烟者、活跃吸烟者和无需氧疗的间质性肺病(ILD)患者在适度运动时的临床参数的影响:在一项前瞻性观察试验研究中,参与者分别在不佩戴面罩、佩戴外科面罩、佩戴合适的 FFP2 型面罩和佩戴带阀 FFP3 型面罩的情况下进行了六分钟步行测试。对呼吸频率、血压、心率、血气分析参数、呼吸困难和六分钟步行距离进行了测量。结果:21 名健康参与者、17 名没有已知肺部疾病的活跃吸烟者和 15 名间质性肺病患者被纳入研究。与不戴口罩相比,患有 ILD 的参与者在使用 FFP2 口罩时步行距离明显较短、呼吸频率较高且 pO2 较低,但在使用带阀 FFP3 口罩或外科口罩时则不然:结论:对于不需要氧疗的 ILD 患者,佩戴 FFP2 喉罩会对六分钟步行测试中的 pO2、呼吸频率和步行距离产生负面影响。带阀 FFP3 口罩或外科口罩则没有这种影响。
{"title":"Negative impact of face masks in patients with interstitial lung disease: A prospective study.","authors":"Arno Mohr, Stefanie Zahn, Florian Geismann, Stefan Blaas, Michael Pfeifer, Maximilian Malfertheiner, Bernd Salzberger, Frank Hanses, Stilla Bauernfeind, Myriam Koch, Florian Hitzenbichler","doi":"10.1055/a-2361-4723","DOIUrl":"https://doi.org/10.1055/a-2361-4723","url":null,"abstract":"<p><strong>Introduction: </strong>Face masks increase airway resistance, data on the actual extent of this effect are scarce. The aim of this study was to assess the effect of different mask types on clinical parameters during moderate exercise in healthy non-smokers, active smokers and patients with interstitial lung disease (ILD) without the need of oxygen therapy.</p><p><strong>Methods: </strong>In a prospective observational pilot study participants performed a six-minute walk test without mask, with a surgical mask, a well-fitted FFP2 mask and with a valved FFP3 mask. Respiratory rate, blood pressure, heart rate, blood gas analysis parameters, dyspnoea and six-minute walk distance were measured. Data were analysed in an ANOVA model.</p><p><strong>Results: </strong>21 healthy participants, 17 active smokers without known pulmonary disease and 15 patients with interstitial lung disease were included. Participants with ILD had a significant lower walking distance, a higher respiratory rate and a lower pO<sub>2</sub> when using FFP2 masks, but not with valved FFP3 masks or surgical masks compared to not wearing a mask.</p><p><strong>Conclusion: </strong>For patients with ILD without the need of oxygen therapy wearing an FFP2 mask had a negative impact on pO<sub>2</sub>, respiratory rate and walking distance in the six-minute walk test. This effect was not seen with valved FFP3 masks or surgical masks.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Valsalva and Müller maneuvers: who is who and what is what?] [瓦尔萨尔瓦和缪勒手法:谁是谁,什么是什么?]
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-07-12 DOI: 10.1055/a-2349-1034
Ulrich Koehler, Mikail Aykut Degerli, Olaf Hildebrandt, Wulf Hildebrandt, Heike Korbmacher-Steiner, Peter von Wichert, Thomas Podszus

The original Valsalva manoeuvre (VM) was described in detail by the Italian anatomist, physician and surgeon Antonio Maria Valsalva (1666-1723). The VM consists of a voluntary forced expiratory effort against a closed upper airway. It was used tradionally in otolaryngology for testing the openess of the eustachian tubes and expelling pus/fluid from the middle to the external ear. VM is associated with increased intrathoracic and -abdominal pressure and leads to hemodynamic changes. The use of VM for cardiovascular purposes was first described by Eduard Friedrich Weber, a German physiologist. The Müller manoeuvre (MM) represents the opposite of the VM by forced inspiration against a closed upper airway. Negative intrathoracic and abdominal pressure (ITP) with direct effects on cardiac function and hemodynamics can be generated by the MM. MM has also been used to simulate the hemodynamic effects of negative ITP in obstructive sleep apnea patients. The Müller manoeuvre was first described by the German anatomist and physician Johannes Müller (1801-1858).

最初的瓦尔萨尔瓦动作(VM)由意大利解剖学家、内科医生和外科医生安东尼奥-玛丽亚-瓦尔萨尔瓦(Antonio Maria Valsalva,1666-1723 年)详细描述。VM 包括在上气道关闭的情况下自主用力呼气。传统上,它被用于耳鼻喉科测试咽鼓管是否通畅,以及将脓液/液体从中耳排出到外耳。VM 与胸腔内和腹腔压力增加有关,并导致血液动力学变化。德国生理学家爱德华-弗里德里希-韦伯(Eduard Friedrich Weber)首次将 VM 用于心血管目的。Müller manoeuvre(MM)与 VM 相反,是在关闭上气道的情况下强制吸气。缪勒动作可产生胸腹负压(ITP),直接影响心脏功能和血液动力学。MM还可用于模拟阻塞性睡眠呼吸暂停患者负ITP对血液动力学的影响。德国解剖学家和医生约翰内斯-缪勒(Johannes Müller,1801-1858 年)首次描述了缪勒动作。
{"title":"[Valsalva and Müller maneuvers: who is who and what is what?]","authors":"Ulrich Koehler, Mikail Aykut Degerli, Olaf Hildebrandt, Wulf Hildebrandt, Heike Korbmacher-Steiner, Peter von Wichert, Thomas Podszus","doi":"10.1055/a-2349-1034","DOIUrl":"https://doi.org/10.1055/a-2349-1034","url":null,"abstract":"<p><p>The original Valsalva manoeuvre (VM) was described in detail by the Italian anatomist, physician and surgeon Antonio Maria Valsalva (1666-1723). The VM consists of a voluntary forced expiratory effort against a closed upper airway. It was used tradionally in otolaryngology for testing the openess of the eustachian tubes and expelling pus/fluid from the middle to the external ear. VM is associated with increased intrathoracic and -abdominal pressure and leads to hemodynamic changes. The use of VM for cardiovascular purposes was first described by Eduard Friedrich Weber, a German physiologist. The Müller manoeuvre (MM) represents the opposite of the VM by forced inspiration against a closed upper airway. Negative intrathoracic and abdominal pressure (ITP) with direct effects on cardiac function and hemodynamics can be generated by the MM. MM has also been used to simulate the hemodynamic effects of negative ITP in obstructive sleep apnea patients. The Müller manoeuvre was first described by the German anatomist and physician Johannes Müller (1801-1858).</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141601352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ). 德文版哮喘损害和风险问卷(AIRQ)的验证。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-07-11 DOI: 10.1055/a-2346-9840
Frank Kanniess, Kerstin Defosse, Marek Lommatzsch, Thomas Schultz, Hartmut Timmermann, Olaf Schmidt, Stefan Heindl, Hans Jörg Baumann, Roland Buhl, Christian Taube, Fabian Höing, Stephanie Korn

Background: The Asthma Impairment and Risk Questionnaire (AIRQ), a 10-item, equally weighted, yes/no tool assessing symptom impairment and risk of exacerbations in patients with asthma aged ≥12 years, was developed and validated in a US patient population to evaluate varying levels of asthma control. This study aimed to validate the German language version of the AIRQ in patients aged ≥12 years with different levels of asthma control.

Methods: A cross-sectional, observational, multi-centre study comprising a single visit was conducted in multiple specialised asthma centres and general practices in Germany. A total of 300 patients completed the following measures: 1) Patient Sociodemographic and Clinical Questionnaire, 2) AIRQ, 3) Asthma Control Test (ACT), and 4) Asthma Control Questionnaire (ACQ-6). Logistic regression analyses were conducted to assess the AIRQ score cut points with the greatest predictive validity in discriminating between different control levels relative to a standard of ACT plus prior-year exacerbations or ACQ-6 plus prior-year exacerbations.

Results: The German version of the AIRQ demonstrated a robust capability to correctly identify well-controlled versus not well- or very poorly controlled (AUC values of 0.90 or higher) and well- or not well-controlled versus very poorly controlled asthma (AUC values of 0.89 or higher).

Conclusions: The German version of the AIRQ is a suitable tool to identify adults with varying levels of asthma control, which in turn can help to accurately identify patients with uncontrolled asthma in clinical practice.

背景:哮喘损害和风险问卷(AIRQ)是一种评估年龄≥12岁的哮喘患者的症状损害和病情恶化风险的10个项目、权重相同的是/否工具,该问卷是在美国患者群体中开发和验证的,用于评估不同的哮喘控制水平。本研究旨在对不同哮喘控制水平的≥12岁患者进行德语版AIRQ的验证:方法:在德国多个哮喘专科中心和全科诊所开展了一项横断面、观察性、多中心研究,包括一次就诊。共有 300 名患者完成了以下测量:1)患者社会人口学和临床问卷;2)AIRQ;3)哮喘控制测试(ACT);4)哮喘控制问卷(ACQ-6)。我们进行了逻辑回归分析,以评估相对于 ACT 加前一年哮喘加重或 ACQ-6 加前一年哮喘加重的标准,AIRQ 分数切点在区分不同控制水平方面具有最大的预测效力:德文版 AIRQ 具有强大的能力,可正确识别哮喘控制良好与控制不佳或控制极差(AUC 值为 0.90 或更高),以及哮喘控制良好与控制不佳或控制极差(AUC 值为 0.89 或更高):结论:德文版 AIRQ 是一种合适的工具,可用于识别哮喘控制水平不同的成人,从而有助于在临床实践中准确识别哮喘失控患者。
{"title":"Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ).","authors":"Frank Kanniess, Kerstin Defosse, Marek Lommatzsch, Thomas Schultz, Hartmut Timmermann, Olaf Schmidt, Stefan Heindl, Hans Jörg Baumann, Roland Buhl, Christian Taube, Fabian Höing, Stephanie Korn","doi":"10.1055/a-2346-9840","DOIUrl":"https://doi.org/10.1055/a-2346-9840","url":null,"abstract":"<p><strong>Background: </strong>The Asthma Impairment and Risk Questionnaire (AIRQ), a 10-item, equally weighted, yes/no tool assessing symptom impairment and risk of exacerbations in patients with asthma aged ≥12 years, was developed and validated in a US patient population to evaluate varying levels of asthma control. This study aimed to validate the German language version of the AIRQ in patients aged ≥12 years with different levels of asthma control.</p><p><strong>Methods: </strong>A cross-sectional, observational, multi-centre study comprising a single visit was conducted in multiple specialised asthma centres and general practices in Germany. A total of 300 patients completed the following measures: 1) Patient Sociodemographic and Clinical Questionnaire, 2) AIRQ, 3) Asthma Control Test (ACT), and 4) Asthma Control Questionnaire (ACQ-6). Logistic regression analyses were conducted to assess the AIRQ score cut points with the greatest predictive validity in discriminating between different control levels relative to a standard of ACT plus prior-year exacerbations or ACQ-6 plus prior-year exacerbations.</p><p><strong>Results: </strong>The German version of the AIRQ demonstrated a robust capability to correctly identify well-controlled versus not well- or very poorly controlled (AUC values of 0.90 or higher) and well- or not well-controlled versus very poorly controlled asthma (AUC values of 0.89 or higher).</p><p><strong>Conclusions: </strong>The German version of the AIRQ is a suitable tool to identify adults with varying levels of asthma control, which in turn can help to accurately identify patients with uncontrolled asthma in clinical practice.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and "harm reduction"]. [欧洲呼吸学会关于新型尼古丁和烟草制品及其在烟草控制和 "减害 "中的作用的声明]。
IF 1.2 Q4 RESPIRATORY SYSTEM Pub Date : 2024-07-01 Epub Date: 2024-04-26 DOI: 10.1055/a-2298-8015
Stefan Andreas, Daniel Tzu-Hsuan Chen, Jonathan Grigg, Filippos T Filippidis
{"title":"[European Respiratory Society statement on novel nicotine and tobacco products, their role in tobacco control and \"harm reduction\"].","authors":"Stefan Andreas, Daniel Tzu-Hsuan Chen, Jonathan Grigg, Filippos T Filippidis","doi":"10.1055/a-2298-8015","DOIUrl":"10.1055/a-2298-8015","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1